POPA ReconTop 10 Stocks by 3-Year Revenue Growth With MC Above $100M
Top 10 Stocks by 3-Year Revenue Growth With MC Above $100M CorMedix leads with revenue up 2,231% over three years, followed by vTv Therapeutics at +1,500% and TON Strategy at +1,233%. Six of the ten are biotech companies - and the list says as much about where each started as where it got to. Growth of 1,500% on $36.8M of revenue is a different achievement than 484% on $9.9B, and both sit in the same table. What separates them is what the market pays for it: CorMedix trades at 1.3x revenue, QXO at 1.5x, while ImmunityBio carries $8.39B of market cap on $165.8M about 51x and Bitmine Immersi…
The excerpt is quoted from a public Telegram channel, which owns its text.
Read the original post on Telegram
More posts from Top 7 | Tech, AI & Crypto Analytics · All channels